DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Managing CAR-T Failure: Chidamide & PD-1 Blockade in LBCL May 14, 2024
FL (Follicular Lymphoma),Lymphoma Loncastuximab & Rituximab Combo: Effective in Rel/Ref FL May 08, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Optimizing CAR-T Outcomes: Effective Bridging Strategies May 08, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma eIF3a in DLBC: Prognostic Biomarker +Therapeutic Target Apr 30, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Enhancing CAR-T Therapy With Nivolumab: Final Analysis Apr 25, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Combination Therapy: HDT/ASCT With CNCT19 Apr 25, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Predictive Model: DLBCL Mortality Risk Factors Apr 23, 2024
